Press release - 16/07/2012 Winners of the "Science2Start" ideas competition honoured BioRegio STERN Management GmbH honoured the three winners of the regional "Science2Start" ideas competition last Thursday evening. The award ceremony was part of the traditional summer soirée given by BioRegio STERN Management GmbH in collaboration with TTR Technologieparks Tübingen-Reutlingen GmbH, the Verein zur Förderung der Biotechnologie und der Medizintechnik e.V. (Society for the Promotion of Biotechnology and Medical Technology)…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/winners-of-the-science2start-ideas-competition-honoured
Article - 05/02/2008 Protecting the liver from oxygen stress The Emmy Noether junior research group in the Department of Surgery at the University Hospital of Heidelberg is to be funded with 1.2 million over the next five years. The group will focus on how tissue damage in donor livers can be prevented. The group headed by Dr. Martin Schneider.https:////www.gesundheitsindustrie-bw.de/en/article/news/protecting-the-liver-from-oxygen-stress
Press release - 27/11/2010 New metabolic model provides insights into Alzheimer’s disease The combination of a newly developed bioinformatic model and experimental data provides new insights into the causes of Alzheimers disease. Researchers found that whilst the activity of a particular enzyme is reduced specific nerve cells are able to counteract this deficiency by rerouting the metabolic fluxes.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/new-metabolic-model-provides-insights-into-alzheimer-s-disease
Article - 17/02/2009 Tissue engineering companies and EU obstacles With the new regulation on advanced therapy medicinal products the European Union has tried to establish legal certainty with regard to gene therapy somatic cell therapy and tissue engineering products. However Dr. Heinz W. Joseph of TETEC AG is sure that the new guidelines will lead to problems for small and medium-sized companies. https:////www.gesundheitsindustrie-bw.de/en/article/news/tissue-engineering-companies-and-eu-obstacles
Article - 04/10/2010 Computer models for underestimated all-rounders It has now become clear that non-coding RNAs are the puppeteers in cells. Prof. Dr. Rolf Backofens team at the University of Freiburg is developing an indispensable tool for doing just this in the form of computer programmes that generate two-dimensional structural models of these tiny all-rounders.https:////www.gesundheitsindustrie-bw.de/en/article/news/computer-models-for-underestimated-all-rounders
Press release - 27/01/2009 Survey results show the biotech sector is cautiously optimistic Despite the current financial crisis more than 90 of German biotech companies consider their current situation to be good 48 or satisfactory 43. So say the results of a survey carried out by the German Biotechnology Industry Organisation BIO Deutschland and the life sciences journal transkript.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/survey-results-show-the-biotech-sector-is-cautiously-optimistic
Article - 07/01/2016 New protein helps B cells generate an effective immune response The human immune system plays a key role for human health. Dr. Gina Fiala, a scientist in Prof. Dr. Wolfgang Schamel’s team in the Department of Immunology at Freiburg University, has discovered Kidins220/ARMS in B cells. Kidins220/ARMS is part of the adaptive immune system where it plays a key role in the maturation of B cells.https:////www.gesundheitsindustrie-bw.de/en/article/news/kidins220-hilft-b-zellen-bei-der-immunabwehr
Article - 19/04/2017 Are start-ups a matter for the boss? A professor’s thoughts on university spin-offs Research work and entrepreneurship are by no means mutually exclusive. There are numerous successful university spin-offs in the life sciences sector that prove this only too well. However, the road from a good idea to a commercially successful company can be long and arduous. Those who benefit from the support of their boss from the outset can consider themselves extremely fortunate. Prof. Dr. Hans-Georg Rammensee talks about his experience with…https:////www.gesundheitsindustrie-bw.de/en/article/news/are-start-ups-a-matter-for-the-boss-a-professors-thoughts-on-university-spin-offs
Dossier - 13/05/2013 The human proteome – the next major goal The “Human Proteome Project”, a ten-year global initiative that is making a systematic effort to map all human proteins, has moved from the planning to the experimental stage. How significant and how effective the project will be depends on how much the resources offered are used by proteome researchers and on the data that the researchers bring into the project. https:////www.gesundheitsindustrie-bw.de/en/article/dossier/the-human-proteome-the-next-major-goal
Article - 03/12/2008 Esslingen scientists to recalculate human age The actual age of a person not only depends on the date he or she was born. Biological age, which is far more important in determining lifespan, can so far only be estimated rather than precisely calculated. The European MARK-AGE research project is working on finding a solution to this problem. Esslingen plays a major role in this project for two reasons: the structure of the city and the company BioTeSys.https:////www.gesundheitsindustrie-bw.de/en/article/news/esslingen-scientists-to-recalculate-human-age
Article - 31/03/2014 The growing significance of peptide therapeutics The therapeutic use of peptides lags behind that of proteins. And there are good reasons for this. However, it seems that this is beginning to change and that peptide therapeutics are growing in significance. As a matter of fact, peptides have become rather popular candidates for drugs. https:////www.gesundheitsindustrie-bw.de/en/article/news/the-growing-significance-of-peptide-therapeutics
Press release - 15/09/2020 ELLIS inaugurates 30 research units at leading institutions across Europe At a virtual event on Tuesday, the European Laboratory for Learning and Intelligent Systems presented the broad scope of research its units will cover in the field of modern AI.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/ellis-offizieller-start-der-30-forschungseinheiten-fuehrenden-institutionen-ganz-europa
Article - 29/04/2010 The biopharmaceutical industry remained stable in times of crisis The German biopharmaceutical industry has come through 2009 without experiencing too many major slumps. The roaring growth of the biopharmaceutical industry in previous years has been replaced by more moderate growth. This is the result published by the 4th Medical Biotechnology report in 2010 compiled on behalf of the biotech interest group of the vfa bio Association of Research-Oriented Pharmaceutical Companies by the Boston Consulting Group. https:////www.gesundheitsindustrie-bw.de/en/article/news/the-biopharmaceutical-industry-remained-stable-in-times-of-crisis
Article - 07/06/2017 A gene that regulates body heat and fat storage Researchers from Heidelberg have shown that the organismal balance between heat production and energy storage is regulated by a gene called THADA. In animal experiments, knocking out the THADA gene leads to excessive food intake, obesity and sensitivity to cold. As humans spread throughout the world and settled in different climate zones, THADA was exposed to high selection pressure due to evolutionary adaptation. This explains why human…https:////www.gesundheitsindustrie-bw.de/en/article/news/a-gene-that-regulates-body-heat-and-fat-storage
Article - 04/07/2017 Ruxolitinib – successful graft-versus-host disease treatment Graft-versus-host disease is a serious complication in leukaemia patients who have been given a blood stem cell transplant from a genetically different person. Prof. Dr. Nikolas von Bubnoff and Prof. Dr. Robert Zeiser from the Department of Haematology, Oncology and Stem Cell Transplantation at Freiburg University Medical Centre initiated a Germany-wide study to show that an active substance called ruxolitinib has a promising therapeutic effect.…https:////www.gesundheitsindustrie-bw.de/en/article/news/ruxolitinib-successful-graft-versus-host-disease-treatment
Article - 14/07/2014 Andreas Marx – “Chemical Biology” of DNA polymerases Whether inside the cell or in molecular biology laboratories, the synthesis of DNA would not be possible without DNA polymerases. The regulation and application of this versatile enzyme family is the subject of research carried out by Prof. Dr. Andreas Marx at the University of Konstanz in Southern Germany. In addition to basic research into naturally occurring DNA polymerases, Marx deals with the development of novel polymerases that can be used…https:////www.gesundheitsindustrie-bw.de/en/article/news/andreas-marx-chemical-biology-of-dna-polymerases
Article - 30/03/2009 Innovative sunscreen for noninvasive therapies The importance of sunlight for human health becomes particularly obvious when people do not receive sufficient sunlight. A prime example of this is rachitis also known as English disease which is caused by vitamin D deficiency. However the exposure to too much sunlight can also be dangerous. The Empfingen-based company HelioVital has now developed a special film that enables the therapeutic use of the positive effects of sunlight without causing…https:////www.gesundheitsindustrie-bw.de/en/article/news/innovative-sunscreen-for-noninvasive-therapies
Article - 08/12/2014 Stefan Hell – a Nobel Prize for a lateral thinker Stefan Hell was awarded the Nobel Prize in Chemistry for the development of STED fluorescence microscopy which has made it possible to obtain optical images well below the optical diffraction limit. However, Hell does not really see himself as a developer. His passion is scientific principles, the identification of how things are connected and the exploration of new, uncharted paths.https:////www.gesundheitsindustrie-bw.de/en/article/news/stefan-hell-a-nobel-prize-for-a-lateral-thinker
Article - 10/06/2008 Heiko Möller - Uncovering molecular structures Professor Heiko Möller teaches chemistry at the University of Constance and is a specialist in nuclear magnetic resonance spectroscopy. He enjoys working with other people including colleagues from the field of chemistry and also biologists and tropical disease specialists. Möller returned from the USA to accept a junior professor position at Constance University.https:////www.gesundheitsindustrie-bw.de/en/article/news/heiko-moeller-uncovering-molecular-structures
Article - 14/07/2009 Tiny particles are a weapon against tumours Prostate carcinoma is one of the most common malignant diseases claiming more than 84000 lives per year in the EU and the United States. In cooperation with the University of Constance the Thurgau Biotechnology Institute BITg is working on ways to remove prostate carcinomas and other tumours that are difficult to treat by using tiny particles made of biologically degradable polyester. Prof. Dr. Marcus Groettrup and his team of researchers have…https:////www.gesundheitsindustrie-bw.de/en/article/news/tiny-particles-are-a-weapon-against-tumours
Article - 11/07/2010 Complex issues relating to membranes Dr. Uwe Schulte of the Freiburg-based biotech company Logopharm GmbH is a specialist in the analysis of membrane proteins membrane protein complexes and functional networks involving membrane proteins. In an interview with BIOPRO Schulte expresses his views on the direction research should take.https:////www.gesundheitsindustrie-bw.de/en/article/news/complex-issues-relating-to-membranes
Article - 11/02/2013 REGiNA – the health region for regenerative medicine REGiNA is a users’ centre for regenerative medicine in the area bordered by the cities of Stuttgart and Tübingen and the Neckar-Alb region. It was established with the aim of translating a variety of advanced regenerative methods into broad clinical application. Providing a diverse and broad range of information, REGiNA is focused on making new treatment possibilities and the opportunities created by regenerative medicine known to doctors,…https:////www.gesundheitsindustrie-bw.de/en/article/news/regina-the-health-region-for-regenerative-medicine
Article - 12/07/2010 Twelve in one fell swoop – New type 2 diabetes genes An international team of scientists working on the largest diabetes study to date have found 12 new diabetes genes in around 140000 Europeans. One of the authors the endocrinologist Bernhard Böhm from Ulm considers the findings to be a breakthrough in the research and treatment of type 2 diabetes. https:////www.gesundheitsindustrie-bw.de/en/article/news/twelve-in-one-fell-swoop-new-type-2-diabetes-genes
Press release - 05/09/2017 Cell marking opens up a window into the body A new and particularly reliable method for marking cells can simplify research into diseases such as myocardial infarction, diabetes or Alzheimer's and reduce the use of test animals: Scientists from the University of Tübingen have developed a method by which they can target specific cell types in mice and monitor their behavior using positron emission tomography (PET). PET-based cell tracking allows scientists to observe complex life…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/cell-marking-opens-up-a-window-into-the-body
Press release - 03/08/2009 An investment in the future is being made at the University of Constance A few weeks ago the Max Planck Society approved the establishment of a new International Max Planck Research School IMPRS for Organismal Biology at the Excellence University of Constance. The International Research School will be established in order to investigate the complex interactions between the organism and environment as well as between organisms. https:////www.gesundheitsindustrie-bw.de/en/article/press-release/an-investment-in-the-future-is-being-made-at-the-university-of-constance